CONMED 配当と自社株買い
配当金 基準チェック /36
CONMED配当を支払う会社であり、現在の利回りは1.11%で、収益によって十分にカバーされています。
主要情報
1.1%
配当利回り
n/a
バイバック利回り
総株主利回り | n/a |
将来の配当利回り | 1.1% |
配当成長 | -9.1% |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | US$0.800 |
配当性向 | 19% |
最近の配当と自社株買いの更新
Recent updates
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem
Nov 07Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 02Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?
Oct 01Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price
Sep 12CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20
Aug 15CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price
Jul 17AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation
Jun 21There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding
Jun 01Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Apr 18Is CONMED (NYSE:CNMD) Using Too Much Debt?
Mar 28CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%
Feb 15US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results
Feb 03Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?
Jan 08Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects
Dec 18CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt
Nov 30Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Oct 28Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?
Sep 22Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?
Aug 24Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly
Jul 28Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?
Jun 08These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively
May 17Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Apr 28Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching
Mar 10Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden
Feb 14CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M
Feb 02Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)
Jan 24ConMed: Still Fairly Priced, Turning More Constructive
Dec 09At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?
Nov 18Conmed withdraws FY22 guidance on software implementation-related disruption
Nov 15CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet
Oct 11決済の安定と成長
配当データの取得
安定した配当: CNMDの1株当たり配当金は過去10年間安定しています。
増加する配当: CNMDの配当金は過去10年間増加していません。
配当利回り対市場
CONMED 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (CNMD) | 1.1% |
市場下位25% (US) | 1.4% |
市場トップ25% (US) | 4.4% |
業界平均 (Medical Equipment) | 1.7% |
アナリスト予想 (CNMD) (最長3年) | 1.1% |
注目すべき配当: CNMDの配当金 ( 1.11% ) はUS市場の配当金支払者の下位 25% ( 1.39% ) と比べると目立ったものではありません。
高配当: CNMDの配当金 ( 1.11% ) はUS市場の配当金支払者の上位 25% ( 4.38% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: CNMDは低い 配当性向 ( 18.7% ) であるため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: CNMDは 現金配当性向 ( 14.9% ) が低いため、配当金の支払いはキャッシュフローによって完全にカバーされています。